ENDRA Life Sciences Inc.
NDRA
$6.46
$1.1922.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.74M | 356.50K | 762.40K | 794.00K | 1.81M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 47.10K | 180.20K | 205.60K | 254.70K | 44.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.80M | -- | -- | -- | -- |
| Total Current Assets | 5.59M | 536.70K | 968.00K | 1.05M | 1.85M |
|
|
|||||
| Total Current Assets | 5.59M | 536.70K | 968.00K | 1.05M | 1.85M |
| Net Property, Plant & Equipment | 444.30K | 464.70K | 504.50K | 544.00K | 583.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.91M | 2.44M | 2.38M | 371.40K | 371.40K |
| Total Assets | 7.94M | 3.44M | 3.85M | 1.96M | 2.81M |
|
|
|||||
| Total Accounts Payable | 465.00K | 456.80K | 383.00K | 252.50K | 282.00K |
| Total Accrued Expenses | 183.00K | 244.70K | 238.60K | 419.00K | 166.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 138.60K | 134.00K | 129.40K | 128.80K | 128.20K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 786.60K | 835.40K | 751.00K | 800.30K | 576.60K |
|
|
|||||
| Total Current Liabilities | 786.60K | 835.40K | 751.00K | 800.30K | 576.60K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 290.60K | 327.30K | 363.00K | 396.50K | 429.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 555.30K | 488.60K | 479.70K | 595.90K | 328.60K |
| Total Liabilities | 1.63M | 1.65M | 1.59M | 1.79M | 1.33M |
|
|
|||||
| Common Stock & APIC | 118.00M | 113.56M | 112.73M | 107.47M | 107.17M |
| Retained Earnings | -111.62M | -111.78M | -110.47M | -107.30M | -105.70M |
| Treasury Stock & Other | -73.00K | -- | -- | -- | -- |
| Total Common Equity | 6.31M | 1.79M | 2.26M | 171.40K | 1.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.31M | 1.79M | 2.26M | 171.40K | 1.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.31M | 1.79M | 2.26M | 171.40K | 1.47M |
|
|
|||||